Ceva Santé Animale has announced the arrival of a new shareholder, Mérieux Développement, the investment company of Institut Mérieux.
Last June Ceva Santé Animale finalized the group’s 4th LMBO enabling it to pursue its ambitious development program to become one of the top 5 global animal health companies by 2020. Although Ceva management remains the majority shareholder, this financial round welcomed international investors, i.e. Temasek and CDH Investments, alongside with French investors including Euromezzanine and Sagard (longstanding partners of the Group).
It is within the framework of this operation that Mérieux Développement joined as a minority shareholder of Ceva, keen to participate in the emergence of a French world leader in the veterinary sector.
In addition to the funds that the company is bringing, this support from Mérieux Développement offers an international presence of the Institut Mérieux and its companies, especially in China, a key country for Ceva Santé Animale’s future development. The Institut Mérieux has a long history of working with China, and has developed partnerships with the scientific and medical community to cope with their public health priorities.
“The high quality of the management and their teams, their marketing position in avian and swine biology and the large resources allocated to R&D gave us every confidence in Ceva’s ability to pursue its ambitious growth,.” Thierry Chignon, senior partner at Mérieux Développement said.